GlaxoSmithKline Stock
StockStockPrice
Frequently asked questions
What is GlaxoSmithKline's market capitalization?
What is GlaxoSmithKline's Price-to-Earnings (P/E) ratio?
What is the Earnings Per Share (EPS) for GlaxoSmithKline?
What is GlaxoSmithKline's revenue over the trailing twelve months?
What is the EBITDA for GlaxoSmithKline?
What is the free cash flow of GlaxoSmithKline?
What is the 5-year beta of GlaxoSmithKline's stock?
How many employees does GlaxoSmithKline have, and what sector and industry does it belong to?
What is the free float of GlaxoSmithKline's shares?
Financials
Market Cap
$362.67M5Y beta
0.70EPS (TTM)
0.0509Free Float
45.14MP/E ratio (TTM)
22.38Revenue (TTM)
$202.21MEBITDA (TTM)
$29.42MFree Cashflow (TTM)
$8.79MInformation
GlaxoSmithKline Pakistan Limited is a Pakistan-based global biopharma company. The Company is engaged in the manufacturing and marketing of research-based specialties and pharmaceutical products. It caters to therapy areas, such as anti-infectives, dermatology, respiratory, analgesics, urology, and vaccines. Its pharmaceutical brands include Augmentin, Velosef, Amoxil, Dermovate, Clobevate, Betnovate, Calpol and Ventolin. Its portfolio has three product areas: vaccines, specialty, and general medicines. Its Amoxil branded products are an antibiotic indicated for the treatment of upper respiratory tract infections and helicobacter pylori. Its Vates portfolio comprises brands, such as Dermovate, Clobevate, Cutivate, and Betnovate. Its Vates portfolio addresses to a broad category of steroid responsive dermatoses indications, contact, and other kinds of dermatitis. Its Calpol branded products are used for treatment of mild to moderate fever and pain.
1,708
Biotechnology & Drugs
Health Care
Identifier
ISIN
Primary Ticker